Molecular insights into gastrointestinal neuroendocrine tumours: importance and recent advances

被引：27

作者：

Corleto, VD

Delle Fave, G

Jensen, RT

机构：

[1] NIDDK, DB, Digest Dis Branch, NIH, Bethesda, MD 20892 USA

[2] Univ Roma La Sapienza, Div Digest & Liver Dis, I-00185 Rome, Italy

来源：

DIGESTIVE AND LIVER DISEASE | 2002年 / 34卷 / 09期

关键词：

carcinoid; gastrinoma; Multiple Endocrine Neoplasia type-1; pancreatic endocrine turnour;

D O I：

10.1016/S1590-8658(02)80212-2

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

A subset of gastrointestinal neuroendocrine tumours [carcinoids and pancreatic endocrine tumours] show aggressive growth. Early identification of this subset is essential for management; however clinical, laboratory and histologic features frequently fail to achieve this. Currently, there is an increased understanding of the molecular pathogenesis/changes in neuroendocrine tumours and this may identify important prognostic factors and possibly, new treatments. Recent findings and progress in this area are briefly reviewed in this article.

引用

收藏

页码：668 / 680

页数：13

相关论文

共 156 条

[1] EXPRESSION OF ONCOGENES IN THYROID-TUMORS - COEXPRESSION OF C-ERBB2/NEU AND C-ERBB [J].

AASLAND, R ;

LILLEHAUG, JR ;

MALE, R ;

JOSENDAL, O ;

VARHAUG, JE ;

KLEPPE, K .

BRITISH JOURNAL OF CANCER, 1988, 57 (04) :358-363

[2] Menin interacts with the AP1 transcription factor JunD and represses JunD-activated transcription [J].

Agarwal, SK ;

Guru, SC ;

Heppner, C ;

Erdos, MR ;

Collins, RM ;

Park, SY ;

Saggar, S ;

Chandrasekharappa, SC ;

Collins, FS ;

Spiegel, AM ;

Marx, SJ ;

Burns, AL .

CELL, 1999, 96 (01) :143-152

[3] GROWTH-REGULATION IN CARCINOID-TUMORS [J].

AHLMAN, H ;

WANGBERG, B ;

NILSSON, O .

ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 1993, 22 (04) :889-915

[4] Immunohistologic analysis of gastrointestinal and pulmonary carcinoid tumors [J].

Al-Khafaji, B ;

Noffsinger, AE ;

Miller, MA ;

DeVoe, G ;

Stemmermann, GN ;

Fenoglio-Preiser, C .

HUMAN PATHOLOGY, 1998, 29 (09) :992-999

[5]

Angeletti S, 1999, ITAL J GASTROENTEROL, V31, pS108

[6] Involvement of BCL-2 oncoprotein in the development of enterochromaffin-like cell gastric carcinoids [J].

Azzoni, C ;

Doglioni, C ;

Viale, G ;

DelleFave, G ;

DeBoni, M ;

Caruana, P ;

Ferraro, G ;

Bordi, C .

AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1996, 20 (04) :433-441

[7] Deletion at 3p25.3-p23 is frequently encountered in endocrine pancreatic tumours and is associated with metastatic progression [J].

Barghom, A ;

Komminoth, P ;

Bachmann, D ;

Rütimann, K ;

Saremaslani, P ;

Muletta-Feurer, S ;

Perren, A ;

Roth, J ;

Heitz, PU ;

Speel, EJM .

JOURNAL OF PATHOLOGY, 2001, 194 (04) :451-458

[8] Mutations of the DPC4/Smad4 gene in neuroendocrine pancreatic tumors [J].

Bartsch, D ;

Hahn, SA ;

Danichevski, KD ;

Ramaswamy, A ;

Bastian, D ;

Galehdari, H ;

Barth, P ;

Schmiegel, W ;

Simon, B ;

Rothmund, M .

ONCOGENE, 1999, 18 (14) :2367-2371

[9] Low frequency of p16INK4a alterations in insulinomas [J].

Bartsch, DK ;

Kersting, M ;

Wild, A ;

Ramaswamy, A ;

Gerdes, B ;

Schuermann, M ;

Simon, B ;

Rothmund, M .

DIGESTION, 2000, 62 (2-3) :171-177

[10] p53 Tumour suppressor gene expression in pancreatic neuroendocrine tumour cells [J].

Bartz, C ;

Ziske, C ;

Wiedenmann, B ;

Moelling, K .

GUT, 1996, 38 (03) :403-409

← 1 2 3 4 5 6 7 8 9 10 →